Malignant Melanoma
Phase III Trial of Bcl-2 Antisense Plus Chemotherapy Begins
Published in Cancer Weekly, August 1st, 2000
This investigational study will examine the safety and efficacy of G3139 combined with dacarbazine (DTIC). The trial, sponsored by Genta, Inc., will involve major cancer centers and oncology practices in North America and Europe.
At the Annual Meeting of the American Association for Cancer Research, held in San Francisco, California, during April 2000, Dr. Burkhard Jansen from the University of Vienna...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2000-08-01)
More Articles from Cancer Weekly
- Breast Cancer
Epidermal Growth Factor Receptor Variant Promotes Tumor Formation - Cancer Gene Therapy
p53 Gene Transfer Inhibits Anaplastic Large Cell Lymphoma in vivo - Colon Cancer
Study Finds Colonoscopy May be Best Way to Screen - Adverse Drug Effects
Report Urges Closer Look at Cardiotoxicity of Breast Cancer Drug Trastuzumab (Herceptin) - Breast Cancer
Variability in Cancer Registration in U.K. May Distort Statistics - Cancer Gene Therapy
p53 Gene Transfer Inhibits p53-Mutated Human Melanoma Cells - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
